Tissue Regenix Group PLC (LSE:TRX) - Share price - Overview

Stock Report

Tissue Regenix Group PLC TRX

Last Price
GBX15.00

Day Change
-0.25|-1.64%

As of 18/08/2017
16:14:44 BST | GBX
Minimum 15 Minutes Delay.

Last Close15.25p
Day Range14.00 - 15.24
Mkt Cap174.20Mil
52-Wk Range10.65 - 21.00
Yield %0.00
ISINGB00B5SGVL29
Volume1,045,887
P/E-10.67
P/S72.46
P/CF-9.78

Share Price

Total Returns 18/08/2017

 Chg (%)  
More ...
Tissue Regenix Group PLC20.00 
FTSE 100 TR GBP-0.08
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.001.57
Operating Profit-6.58-8.37-12.05
Net Profit-5.59-7.58-10.80
Reported EPS-0.88-1.19-1.41
Balance Sheet
Current Assets19.6112.2411.96
Non Current Assets0.470.441.64
Total Assets20.0812.6713.60
Current Liabilities1.101.102.07
Total Liabilities1.101.102.07
Total Equity18.9811.5811.54
Cash Flow
Operating Cash Flow-5.65-8.29-11.78
Net Change in Cash-5.72-8.23-12.79
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-13.25-1.51--9.95---
2018-9.60-1.30--11.54---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
09/08/2017PurchaseMr. John Samuel10.002,000,000200,000.00
09/08/2017PurchaseMr. Jon Glenn10.00600,00060,000.00
09/08/2017PurchaseMr. Anthony Odell10.00150,00015,000.00
09/08/2017PurchaseMr. Steven Couldwell10.00300,00030,000.00

Company Profile

Tissue Regenix Group PLC is a biotechnology company. Its business includes the development of regenerative products using its dcell technology.

Sector

Biotechnology

Market Position

752 of 1846 Companies

Index

FTSE AIM All Share

Outlook

(02/06/2017) "... It is well placed for future growth"

Next Event 31/10/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-10.8913.6616.54
Div Yld (E)0.004.064.24
PEG (E)0.000.631.10
ROCE-108.56184.4110.59
Op Mrgn-766.46-5.823.62
EPS Grwth0.0028.5222.92
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. John Samuel
Chief Executive OfficerMr. Anthony Odell
Group Finance Director & Company SecretaMr. Paul Devlin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.